ES2632171T3 - Hidroxiapatita sustituida con silicato - Google Patents
Hidroxiapatita sustituida con silicato Download PDFInfo
- Publication number
- ES2632171T3 ES2632171T3 ES09796031.4T ES09796031T ES2632171T3 ES 2632171 T3 ES2632171 T3 ES 2632171T3 ES 09796031 T ES09796031 T ES 09796031T ES 2632171 T3 ES2632171 T3 ES 2632171T3
- Authority
- ES
- Spain
- Prior art keywords
- hydroxyapatite
- silicate
- molar ratio
- silicon
- range
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229910052588 hydroxylapatite Inorganic materials 0.000 title claims abstract description 126
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical class [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 title claims description 122
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical group [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 title claims description 69
- 239000011575 calcium Substances 0.000 claims abstract description 139
- 239000001506 calcium phosphate Substances 0.000 claims abstract description 17
- 235000011010 calcium phosphates Nutrition 0.000 claims abstract description 15
- 229910000389 calcium phosphate Inorganic materials 0.000 claims abstract description 13
- 229910052909 inorganic silicate Inorganic materials 0.000 claims abstract description 4
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 80
- 229910052710 silicon Inorganic materials 0.000 claims description 77
- 239000010703 silicon Substances 0.000 claims description 70
- 239000000376 reactant Substances 0.000 claims description 59
- 229910052698 phosphorus Inorganic materials 0.000 claims description 25
- 229910052791 calcium Inorganic materials 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 23
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 22
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 claims description 21
- 239000011574 phosphorus Substances 0.000 claims description 21
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 20
- 239000000920 calcium hydroxide Substances 0.000 claims description 20
- 229910001861 calcium hydroxide Inorganic materials 0.000 claims description 20
- 238000006243 chemical reaction Methods 0.000 claims description 19
- 230000008569 process Effects 0.000 claims description 18
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 claims description 12
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 claims description 12
- 229910052586 apatite Inorganic materials 0.000 claims description 11
- 239000000292 calcium oxide Substances 0.000 claims description 11
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical class [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 claims description 11
- 229910019142 PO4 Inorganic materials 0.000 claims description 10
- 239000012535 impurity Substances 0.000 claims description 10
- 238000001556 precipitation Methods 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 9
- 238000001354 calcination Methods 0.000 claims description 9
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 239000010452 phosphate Substances 0.000 claims description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 5
- 239000002244 precipitate Substances 0.000 claims description 4
- 239000003519 biomedical and dental material Substances 0.000 claims description 3
- 150000004760 silicates Chemical class 0.000 claims description 3
- 150000003961 organosilicon compounds Chemical group 0.000 claims description 2
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 claims description 2
- 239000012071 phase Substances 0.000 description 63
- 239000000243 solution Substances 0.000 description 55
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 48
- 239000000203 mixture Substances 0.000 description 40
- 239000000463 material Substances 0.000 description 36
- 238000010438 heat treatment Methods 0.000 description 34
- 238000002441 X-ray diffraction Methods 0.000 description 31
- 230000015572 biosynthetic process Effects 0.000 description 29
- 238000003786 synthesis reaction Methods 0.000 description 28
- 235000011007 phosphoric acid Nutrition 0.000 description 27
- 239000000843 powder Substances 0.000 description 27
- 239000000725 suspension Substances 0.000 description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 description 19
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 18
- -1 polyethylene Polymers 0.000 description 18
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical group [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 18
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 15
- 210000000988 bone and bone Anatomy 0.000 description 15
- 238000006467 substitution reaction Methods 0.000 description 15
- 239000011541 reaction mixture Substances 0.000 description 14
- 239000000047 product Substances 0.000 description 13
- 239000000919 ceramic Substances 0.000 description 12
- 239000008367 deionised water Substances 0.000 description 12
- 229910021641 deionized water Inorganic materials 0.000 description 12
- 238000013461 design Methods 0.000 description 12
- 239000007943 implant Substances 0.000 description 12
- 150000002500 ions Chemical class 0.000 description 12
- 239000002245 particle Substances 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 11
- 150000001875 compounds Chemical class 0.000 description 10
- 239000013078 crystal Substances 0.000 description 10
- 239000012065 filter cake Substances 0.000 description 10
- 229910021529 ammonia Inorganic materials 0.000 description 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 9
- 238000002791 soaking Methods 0.000 description 9
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 8
- 239000012620 biological material Substances 0.000 description 8
- 229910001424 calcium ion Inorganic materials 0.000 description 8
- 230000008859 change Effects 0.000 description 8
- 239000007900 aqueous suspension Substances 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 7
- 239000011521 glass Substances 0.000 description 7
- 238000005245 sintering Methods 0.000 description 7
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 6
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 6
- 239000000378 calcium silicate Substances 0.000 description 6
- 229910052918 calcium silicate Inorganic materials 0.000 description 6
- 238000012512 characterization method Methods 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 235000021317 phosphate Nutrition 0.000 description 6
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 5
- 239000002131 composite material Substances 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- 229910003471 inorganic composite material Inorganic materials 0.000 description 5
- 239000004570 mortar (masonry) Substances 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- 238000001157 Fourier transform infrared spectrum Methods 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000004621 biodegradable polymer Substances 0.000 description 4
- 229920002988 biodegradable polymer Polymers 0.000 description 4
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 4
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical class [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 239000002210 silicon-based material Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 239000003462 bioceramic Substances 0.000 description 3
- 239000000316 bone substitute Substances 0.000 description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 description 3
- 239000006143 cell culture medium Substances 0.000 description 3
- 239000004568 cement Substances 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 150000002894 organic compounds Chemical class 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 239000012265 solid product Substances 0.000 description 3
- 229920002994 synthetic fiber Polymers 0.000 description 3
- 238000004876 x-ray fluorescence Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000005313 bioactive glass Substances 0.000 description 2
- 239000005312 bioglass Substances 0.000 description 2
- 230000004097 bone metabolism Effects 0.000 description 2
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000002241 glass-ceramic Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 150000002484 inorganic compounds Chemical class 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229920005615 natural polymer Polymers 0.000 description 2
- 229910000392 octacalcium phosphate Inorganic materials 0.000 description 2
- 230000011164 ossification Effects 0.000 description 2
- 238000010951 particle size reduction Methods 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- 229920000747 poly(lactic acid) Polymers 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- YIGWVOWKHUSYER-UHFFFAOYSA-F tetracalcium;hydrogen phosphate;diphosphate Chemical compound [Ca+2].[Ca+2].[Ca+2].[Ca+2].OP([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O YIGWVOWKHUSYER-UHFFFAOYSA-F 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 2
- 235000019731 tricalcium phosphate Nutrition 0.000 description 2
- 229940078499 tricalcium phosphate Drugs 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- 229910014497 Ca10(PO4)6(OH)2 Inorganic materials 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000002449 bone cell Anatomy 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000009614 chemical analysis method Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229910052681 coesite Inorganic materials 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 229910052906 cristobalite Inorganic materials 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000000280 densification Methods 0.000 description 1
- 239000004053 dental implant Substances 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000004993 emission spectroscopy Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 238000001027 hydrothermal synthesis Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 125000004437 phosphorous atom Chemical group 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920001610 polycaprolactone Polymers 0.000 description 1
- 239000004632 polycaprolactone Substances 0.000 description 1
- 229910021420 polycrystalline silicon Inorganic materials 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229910021426 porous silicon Inorganic materials 0.000 description 1
- 230000010069 protein adhesion Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- JXJTWJYTKGINRZ-UHFFFAOYSA-J silicon(4+);tetraacetate Chemical compound [Si+4].CC([O-])=O.CC([O-])=O.CC([O-])=O.CC([O-])=O JXJTWJYTKGINRZ-UHFFFAOYSA-J 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 238000003980 solgel method Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910052682 stishovite Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- GBNXLQPMFAUCOI-UHFFFAOYSA-H tetracalcium;oxygen(2-);diphosphate Chemical compound [O-2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GBNXLQPMFAUCOI-UHFFFAOYSA-H 0.000 description 1
- LFQCEHFDDXELDD-UHFFFAOYSA-N tetramethyl orthosilicate Chemical compound CO[Si](OC)(OC)OC LFQCEHFDDXELDD-UHFFFAOYSA-N 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 229910052905 tridymite Inorganic materials 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000009681 x-ray fluorescence measurement Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/12—Phosphorus-containing materials, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B25/00—Phosphorus; Compounds thereof
- C01B25/16—Oxyacids of phosphorus; Salts thereof
- C01B25/26—Phosphates
- C01B25/32—Phosphates of magnesium, calcium, strontium, or barium
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B25/00—Phosphorus; Compounds thereof
- C01B25/16—Oxyacids of phosphorus; Salts thereof
- C01B25/26—Phosphates
- C01B25/32—Phosphates of magnesium, calcium, strontium, or barium
- C01B25/322—Preparation by neutralisation of orthophosphoric acid
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Transplantation (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Engineering & Computer Science (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Dental Preparations (AREA)
- Prostheses (AREA)
- Silicates, Zeolites, And Molecular Sieves (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0900269.2A GB0900269D0 (en) | 2009-01-08 | 2009-01-08 | Silicate-substituted hydroxyapatite |
| GB0900269 | 2009-01-08 | ||
| PCT/GB2009/002954 WO2010079316A1 (en) | 2009-01-08 | 2009-12-23 | Silicate- substituted hydroxyapatite |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2632171T3 true ES2632171T3 (es) | 2017-09-11 |
Family
ID=40379325
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES09796031.4T Active ES2632171T3 (es) | 2009-01-08 | 2009-12-23 | Hidroxiapatita sustituida con silicato |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8545895B2 (enExample) |
| EP (1) | EP2381970B1 (enExample) |
| JP (1) | JP5740314B2 (enExample) |
| AU (1) | AU2009336612B8 (enExample) |
| CA (1) | CA2749018C (enExample) |
| DK (1) | DK2381970T3 (enExample) |
| ES (1) | ES2632171T3 (enExample) |
| GB (1) | GB0900269D0 (enExample) |
| HU (1) | HUE033614T2 (enExample) |
| PL (1) | PL2381970T3 (enExample) |
| PT (1) | PT2381970T (enExample) |
| SI (1) | SI2381970T1 (enExample) |
| WO (1) | WO2010079316A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201010761D0 (en) * | 2010-06-25 | 2010-08-11 | Univ Aberdeen | Bone graft system |
| JP5692587B2 (ja) * | 2011-03-14 | 2015-04-01 | 株式会社リコー | トナー、現像剤、画像形成方法及びプロセスカートリッジ |
| ES2399261B1 (es) * | 2011-09-13 | 2013-10-18 | Universidad De Vigo | Recubrimiento sintético de implante óseo. |
| GB201122405D0 (en) | 2011-12-23 | 2012-02-08 | Univ Aberdeen | Calcium phosphate material |
| RU2500840C1 (ru) * | 2012-07-16 | 2013-12-10 | Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" | Способ получения нанокристаллического кремнийзамещенного гидроксиапатита |
| RU2507151C1 (ru) * | 2012-10-19 | 2014-02-20 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Национальный исследовательский Томский государственный университет" | Способ получения кремниймодифицированного гидроксиапатита с использованием свч-излучения |
| ES2399000B1 (es) * | 2012-12-12 | 2014-01-28 | Biotechnology Institute I Mas D S.L. | Método para producir una estructura porosa de polisfosfato cálcico |
| US9315425B2 (en) | 2013-10-28 | 2016-04-19 | Universiti Brunei Darussalam | Macroporous ceramic body, method of manufacture and uses thereof |
| US10238507B2 (en) | 2015-01-12 | 2019-03-26 | Surgentec, Llc | Bone graft delivery system and method for using same |
| DE102015101626B4 (de) * | 2015-02-04 | 2019-06-27 | Kulzer Gmbh | Beschichtung dentaler, prothetischer Oberflächen mit einer deutlichen Schicht eines synthetischen Hydroxyapatits |
| CN107470012B (zh) * | 2017-07-05 | 2020-04-07 | 昆明理工大学 | 一种磷灰石纯矿物的提取方法 |
| JP7033456B2 (ja) * | 2018-01-24 | 2022-03-10 | 太平洋セメント株式会社 | 歯科用ケイ酸カルシウム水和物系材料 |
| US11116647B2 (en) | 2018-04-13 | 2021-09-14 | Surgentec, Llc | Bone graft delivery system and method for using same |
| US10687828B2 (en) | 2018-04-13 | 2020-06-23 | Surgentec, Llc | Bone graft delivery system and method for using same |
| JP7373330B2 (ja) * | 2018-09-25 | 2023-11-02 | Ｄｏｗａエコシステム株式会社 | ヒドロキシアパタイトの製造方法 |
| US20230120190A1 (en) | 2020-01-29 | 2023-04-20 | Marcelo Rodrigues Teixeira | Oral composition with synergistic association of organic and inorganic components for full maintenance of oral health, process for obtaining and uses thereof |
| GB202012350D0 (en) | 2020-08-07 | 2020-09-23 | Sirakoss Ltd | Method of producing calcium-deficient silicate-substituted calcium phosphate apatite |
| JP7562137B2 (ja) * | 2020-11-17 | 2024-10-07 | 国立研究開発法人産業技術総合研究所 | シリカを担持したリン酸カルシウム結晶 |
| KR102340029B1 (ko) * | 2021-06-29 | 2021-12-16 | 이상진 | 나노 바이오 세라믹스를 함유한 항균 및 항바이러스 제품 |
| CN117281944A (zh) * | 2023-08-25 | 2023-12-26 | 武汉理工大学深圳研究院 | 一种有机/无机复合敷料的制备方法及其应用 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB395713A (en) | 1932-01-19 | 1933-07-19 | George Birch | Improvements in and relating to piston rings |
| DD238619A1 (de) | 1985-06-24 | 1986-08-27 | Univ Schiller Jena | Anorganische - organische verbundwerkstoffe fuer biomedizinische zwecke |
| US4693986A (en) | 1985-06-25 | 1987-09-15 | Orthomatrix, Inc. | Ceramic process and products |
| JP3218401B2 (ja) * | 1991-08-02 | 2001-10-15 | 日本化学工業株式会社 | 防錆顔料組成物 |
| FR2712726B1 (fr) * | 1993-07-15 | 1995-12-15 | Commissariat Energie Atomique | Procédé de conditionnement de déchets radioactifs utilisant des apatites silicatées comme matrice de confinement. |
| US20020136696A1 (en) | 1995-05-19 | 2002-09-26 | Dosuk D. Lee | Orthopedic and dental ceramic implants |
| US5989030A (en) | 1996-01-03 | 1999-11-23 | Suga; Shinichi | Dental implant |
| GB2316940A (en) | 1996-08-30 | 1998-03-11 | Queen Mary & Westfield College | Silicon-substituted hydroxyapatite |
| FI971385A0 (fi) | 1997-04-04 | 1997-04-04 | Bioxid Oy | Biokompatibel komposition, metoder foer dess framstaellning samt anvaendning daerav |
| GB9727049D0 (en) * | 1997-12-22 | 1998-02-18 | Abonetics Ltd | Method for the preparation of carbonated hydroxyapatite compositions |
| CA2318085C (en) | 1998-01-29 | 2012-05-01 | Millenium Biologix Inc. | A synthetic stabilized calcium phosphate biomaterial |
| GB9821663D0 (en) | 1998-10-05 | 1998-11-25 | Abonetics Ltd | Foamed ceramics |
| GB2363115A (en) | 2000-06-10 | 2001-12-12 | Secr Defence | Porous or polycrystalline silicon orthopaedic implants |
| JP4638979B2 (ja) | 2000-10-26 | 2011-02-23 | 宇部マテリアルズ株式会社 | ケイ酸含有アパタイト |
| US6921544B2 (en) * | 2001-03-06 | 2005-07-26 | Rutgers, The State University | Magnesium-substituted hydroxyapatites |
| EP1389978B1 (en) | 2001-05-01 | 2009-01-07 | Amedica Corporation | Radiolucent bone graft |
| CN1294885C (zh) | 2001-06-05 | 2007-01-17 | 江苏阳生生物工程有限公司 | 人体骨组织生物工程支架制品及其制备方法和用途 |
| EP1449818A4 (en) | 2001-10-21 | 2006-12-06 | Nat Inst Of Advanced Ind Scien | POROUS ARTICLE OF FRITTE CALCIUM PHOSPHATE, PROCESS FOR PRODUCTION THEREOF, AND ARTIFICIAL AND HISTOMORPHOLOGICAL SCAFFOLD USING THE SAME |
| DE10161827A1 (de) | 2001-12-15 | 2003-06-26 | Dot Gmbh | Verfahren zur Beschichtung eines Substrats mit Calciumphosphat |
| NZ537093A (en) | 2002-06-19 | 2006-01-27 | Dr | Hydraulic cement based on calcium phosphate for surgical use |
| KR100475828B1 (ko) | 2002-08-30 | 2005-03-10 | 요업기술원 | 산호 유래 인산칼슘계 다공체 및 그 제조방법 |
| SE525236C2 (sv) | 2002-10-31 | 2005-01-11 | Cerbio Tech Ab | Förfarande för framställning av strukturerade keramiska beläggningar och belagda anordningar framställda med detta förfarande |
| GB2395713A (en) | 2002-11-13 | 2004-06-02 | Univ Cambridge Tech | A synthetic bone material |
| WO2004071327A1 (en) | 2003-02-06 | 2004-08-26 | Pentron Clinical Technologies, Llc | Method of manufacturing dental posts, obturators and restorations |
| AU2004212942A1 (en) | 2003-02-14 | 2004-09-02 | Depuy Spine, Inc. | In-situ formed intervertebral fusion device |
| IL155866A0 (en) | 2003-05-12 | 2003-12-23 | Yissum Res Dev Co | Responsive polymeric system |
| US20050074877A1 (en) | 2003-07-28 | 2005-04-07 | Mao Jeremy Jian | Biological engineering of articular structures containing both cartilage and bone |
| US20050100578A1 (en) | 2003-11-06 | 2005-05-12 | Schmid Steven R. | Bone and tissue scaffolding and method for producing same |
| MY144221A (en) | 2004-03-03 | 2011-08-15 | Polynovo Biomaterials Pty Ltd | Biocompatible polymer compositions for dual or multistaged curing. |
| US7498043B2 (en) | 2004-04-07 | 2009-03-03 | Warsaw Orthopedic, Inc. | Silicon substituted oxyapatite |
| US8163030B2 (en) | 2004-05-06 | 2012-04-24 | Degradable Solutions Ag | Biocompatible bone implant compositions and methods for repairing a bone defect |
| AU2005260656B2 (en) | 2004-06-30 | 2011-09-22 | The Board Of Trustees Of The University Of Illinois | Poly (ethylene glycol) - diacrylate- (PEGDA) - crosslinked hydrogels comprising adipogenic mesenchymal stem cells |
| WO2006118554A1 (en) | 2005-05-02 | 2006-11-09 | Shanghai Institute Of Ceramics | A degradable, macroporous bioactive glass scaffold as well as its preparation and manufacturing methods |
| WO2007124511A2 (en) | 2006-04-25 | 2007-11-01 | Washington State University | Resorbable ceramics with controlled strength loss rates |
| US8916198B2 (en) | 2006-04-25 | 2014-12-23 | Washington State University | Mesoporous calcium silicate compositions and methods for synthesis of mesoporous calcium silicate for controlled release of bioactive agents |
| GB2457756A (en) * | 2008-01-09 | 2009-09-02 | Univ Aberdeen | Bioceramic calcium phosphosilicate compositions |
| GB0801935D0 (en) | 2008-02-01 | 2008-03-12 | Apatech Ltd | Porous biomaterial |
-
2009
- 2009-01-08 GB GBGB0900269.2A patent/GB0900269D0/en not_active Ceased
- 2009-12-23 ES ES09796031.4T patent/ES2632171T3/es active Active
- 2009-12-23 PT PT97960314T patent/PT2381970T/pt unknown
- 2009-12-23 DK DK09796031.4T patent/DK2381970T3/en active
- 2009-12-23 AU AU2009336612A patent/AU2009336612B8/en active Active
- 2009-12-23 PL PL09796031T patent/PL2381970T3/pl unknown
- 2009-12-23 CA CA2749018A patent/CA2749018C/en active Active
- 2009-12-23 HU HUE09796031A patent/HUE033614T2/hu unknown
- 2009-12-23 EP EP09796031.4A patent/EP2381970B1/en active Active
- 2009-12-23 SI SI200931688T patent/SI2381970T1/sl unknown
- 2009-12-23 WO PCT/GB2009/002954 patent/WO2010079316A1/en not_active Ceased
- 2009-12-23 JP JP2011544918A patent/JP5740314B2/ja active Active
-
2010
- 2010-01-05 US US12/652,110 patent/US8545895B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| PT2381970T (pt) | 2017-07-13 |
| US8545895B2 (en) | 2013-10-01 |
| HUE033614T2 (hu) | 2017-12-28 |
| AU2009336612B2 (en) | 2015-07-16 |
| SI2381970T1 (sl) | 2017-08-31 |
| AU2009336612A1 (en) | 2011-08-25 |
| PL2381970T3 (pl) | 2017-09-29 |
| AU2009336612A8 (en) | 2015-11-05 |
| DK2381970T3 (en) | 2017-07-03 |
| JP5740314B2 (ja) | 2015-06-24 |
| CA2749018C (en) | 2018-01-23 |
| US20100173009A1 (en) | 2010-07-08 |
| WO2010079316A1 (en) | 2010-07-15 |
| EP2381970A1 (en) | 2011-11-02 |
| GB0900269D0 (en) | 2009-02-11 |
| CA2749018A1 (en) | 2010-07-15 |
| AU2009336612B8 (en) | 2015-11-05 |
| EP2381970B1 (en) | 2017-04-12 |
| JP2012514573A (ja) | 2012-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2632171T3 (es) | Hidroxiapatita sustituida con silicato | |
| Eslami et al. | The comparison of powder characteristics and physicochemical, mechanical and biological properties between nanostructure ceramics of hydroxyapatite and fluoridated hydroxyapatite | |
| Balamurugan et al. | Development and in vitro characterization of sol–gel derived CaO–P2O5–SiO2–ZnO bioglass | |
| RU2354408C2 (ru) | Неорганический резорбируемый материал для замены костей | |
| Philippart et al. | Novel ion-doped mesoporous glasses for bone tissue engineering: Study of their structural characteristics influenced by the presence of phosphorous oxide | |
| ES2321411T3 (es) | Oxiapatita sustituida con silicio. | |
| Tamai et al. | Synthesis of a novel b-tricalcium phosphate/hydroxyapatite biphasic calcium phosphate containing niobium ions and evaluation of its osteogenic properties | |
| Joshy et al. | In vitro sustained release of amoxicillin from lanthanum hydroxyapatite nano rods | |
| ES2692167T3 (es) | Materiales biomédicos | |
| Szurkowska et al. | Novel hybrid material based on Mg2+ and SiO44-co-substituted nano-hydroxyapatite, alginate and chondroitin sulphate for potential use in biomaterials engineering | |
| Coelho et al. | Development and characterization of lanthanides doped hydroxyapatite composites for bone tissue application | |
| KR100652511B1 (ko) | 합성 생체 물질 화합물 | |
| ES2588221T3 (es) | Síntesis de composiciones biocerámicas | |
| Oliveira et al. | Properties of strontium-containing BG 58S produced by alkali-mediated sol-gel process | |
| RU2500840C1 (ru) | Способ получения нанокристаллического кремнийзамещенного гидроксиапатита | |
| AU2006263624B2 (en) | Biomedical materials | |
| Bricha et al. | Hydrothermal synthesis and appraisal of Mg-doped hydroxyapatite nanopowders | |
| Hafezi et al. | Preparation and characterization of whitlockite-merwinite nanocomposite | |
| US20230270915A1 (en) | Calcium-deficient silicate-substituted calcium phosphate apatite compositions and methods | |
| Addou et al. | Synthesis and Characterization of Pure and Co-Substituted ß-TCP Powders: Case of Substitution of Ca2+ by Mg2+ and/or Cu2+ | |
| Kurzyk et al. | Effect of calcination on physicochemical and biological properties of ion-modified nanohydroxyapatite for bone tissue engineering applications | |
| Bricha et al. | A Comparative Study of In Vitro Dissolution Process In Silicon and Magnesium-Substituted Hydroxyapatite Bioceramics. | |
| Oliveira et al. | The Moment of Calcium Nitrate Addition to a Sol-Gel Synthesis Affects the Microstructure and Biological Performance of the Bioactive Glass | |
| Hussain et al. | Development and characterization of lanthanides-doped hydroxyapatite composites for bone tissue application. e-book entitled'Current Trends on Glass and Ceramics Materials, Bentham Sci. Pub., USA/UAE,(2012), Chapter 4, pp87-115. | |
| Jiang | Application of Calcium Phosphate based gels for encapsulation of therapeutic molecules |